• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因芯片法检测临床标本结核分枝杆菌耐药性的应用分析:一项回顾性研究。

Analysis of the application of a gene chip method for detecting Mycobacterium tuberculosis drug resistance in clinical specimens: a retrospective study.

机构信息

The Fourth People's Hospital of Lianyungang City, Lianyungang, 222000, Jiangsu Province, China.

Haibin Rehabilitation Hospital, Lianyungang, Jiangsu Province, China.

出版信息

Sci Rep. 2021 Sep 9;11(1):17951. doi: 10.1038/s41598-021-97559-y.

DOI:10.1038/s41598-021-97559-y
PMID:34504243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8429459/
Abstract

Most Mycobacterium tuberculosis (Mtb) resistant to rifampicin (RIF) has mutations in the rpoB gene, while most Mtb resistant to isoniazid (INH) has mutations in the katG gene or inhA promoter. We used gene chip technology to detect mutations in these genes to determine the resistance of Mtb to RIF and INH. A total of 4148 clinical specimens with sputum smear positivity for acid-fast bacilli (AFB) were detected. Then, taking the results of the drug sensitivity test (DST) as the reference standard, the detection efficiency of sputum samples from different grades of positive smears was compared in detail. We found that the sensitivity of the gene chip method for detecting sputum samples with a grade ≥ AFB 2 + was higher than that of sputum samples with a grade ≤ AFB 1 + (P < 0.05). When the grade of the sample was ≤ AFB 1 +, the sensitivity of the gene chip method was 72.6% for RIF, 67.3% for INH, and 60.0% for MDR-TB. When the grade of the sample was ≥ AFB 2 +, the sensitivity of the gene chip method was 84.5% for RIF, 78.2% for INH, and 73.9% for MDR-TB. The results show that gene chip technology can be directly used to diagnose drug-resistant tuberculosis in clinical specimens, and the diagnostic efficiency for the detection of sputum specimens with a grade ≥ AFB 2 + is better than that of other sputum specimens.

摘要

大多数对利福平(RIF)耐药的结核分枝杆菌(Mtb)在 rpoB 基因中具有突变,而大多数对异烟肼(INH)耐药的 Mtb 在 katG 基因或 inhA 启动子中具有突变。我们使用基因芯片技术检测这些基因中的突变,以确定 Mtb 对 RIF 和 INH 的耐药性。共检测到 4148 例痰涂片抗酸杆菌(AFB)阳性的临床标本。然后,以药敏试验(DST)结果为参考标准,详细比较不同阳性涂片等级的痰标本检测效率。我们发现,基因芯片法检测 AFB 2+及以上等级痰标本的灵敏度高于 AFB 1+及以下等级痰标本(P<0.05)。当样本等级为≤AFB 1+时,基因芯片法检测 RIF 的灵敏度为 72.6%,检测 INH 的灵敏度为 67.3%,检测耐多药结核分枝杆菌(MDR-TB)的灵敏度为 60.0%。当样本等级为≥AFB 2+时,基因芯片法检测 RIF 的灵敏度为 84.5%,检测 INH 的灵敏度为 78.2%,检测 MDR-TB 的灵敏度为 73.9%。结果表明,基因芯片技术可直接用于临床标本中耐药结核分枝杆菌的诊断,且对 AFB 2+及以上等级痰标本的检测诊断效率优于其他痰标本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/eb7a88544bef/41598_2021_97559_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/ff47ca7c0b9b/41598_2021_97559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/ec7176fa1b53/41598_2021_97559_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/9293e76af503/41598_2021_97559_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/eb7a88544bef/41598_2021_97559_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/ff47ca7c0b9b/41598_2021_97559_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/ec7176fa1b53/41598_2021_97559_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/9293e76af503/41598_2021_97559_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/330f/8429459/eb7a88544bef/41598_2021_97559_Fig4_HTML.jpg

相似文献

1
Analysis of the application of a gene chip method for detecting Mycobacterium tuberculosis drug resistance in clinical specimens: a retrospective study.基因芯片法检测临床标本结核分枝杆菌耐药性的应用分析:一项回顾性研究。
Sci Rep. 2021 Sep 9;11(1):17951. doi: 10.1038/s41598-021-97559-y.
2
Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.印度一家三级护理中心对固体培养法与 GenoType MTBDRplus 线探针分析检测法在早期诊断耐多药结核病(MDR-TB)中的比较评估。
PLoS One. 2013 Sep 5;8(9):e72036. doi: 10.1371/journal.pone.0072036. eCollection 2013.
3
Rapid detection of drug-resistant directly from clinical specimens using allele-specific polymerase chain reaction assay.利用等位基因特异性聚合酶链反应检测技术直接从临床标本中快速检测耐药基因。
Indian J Med Res. 2019 Jul;150(1):33-42. doi: 10.4103/ijmr.IJMR_374_18.
4
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.在吉尔吉斯斯坦的耐利福平及异烟肼结核分枝杆菌中 rpoB、katG、inhA 和 ahp 基因突变。
BMC Microbiol. 2018 Mar 22;18(1):22. doi: 10.1186/s12866-018-1168-x.
5
Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.使用雅培实时结核分枝杆菌检测和利福平/异烟肼耐药性检测方法直接检测呼吸道标本中的结核分枝杆菌及耐药性。
Diagn Microbiol Infect Dis. 2017 Oct;89(2):118-124. doi: 10.1016/j.diagmicrobio.2017.06.018. Epub 2017 Jul 1.
6
Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.REBA MTB-Rifa®检测法在快速检测耐利福平结核分枝杆菌中的应用
BMC Infect Dis. 2013 Oct 15;13:478. doi: 10.1186/1471-2334-13-478.
7
Mutational analysis in drug resistant Mycobacterium tuberculosis in Western Uttar Pradesh.在西印度北方邦的耐药结核分枝杆菌中的突变分析。
Indian J Tuberc. 2024;71 Suppl 1:S77-S80. doi: 10.1016/j.ijtb.2024.01.009. Epub 2024 Jan 19.
8
Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.四种方法检测耐多药结核分枝杆菌菌株性能比较。
Int J Tuberc Lung Dis. 2011 Jan;15(1):110-5.
9
Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.异烟肼和利福平耐药突变与二线药物耐药及痰培养转化相关。
J Infect Dis. 2020 Jun 11;221(12):2072-2082. doi: 10.1093/infdis/jiaa042.
10
Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.通过直接测序从痰涂片阳性样本中早期检测耐多药和广泛耐药前结核病
BMC Infect Dis. 2017 Apr 24;17(1):300. doi: 10.1186/s12879-017-2409-6.

引用本文的文献

1
Rapid detection of rifampin resistance in using nucleotide MALDI-TOF MS: a comparative study with phenotypic drug susceptibility testing and DNA sequencing.使用核苷酸基质辅助激光解吸电离飞行时间质谱快速检测利福平耐药性:与表型药物敏感性试验和DNA测序的比较研究。
Microbiol Spectr. 2025 Jul;13(7):e0048325. doi: 10.1128/spectrum.00483-25. Epub 2025 May 30.
2
Efficacy of Xpert MTB/RIF assay in detecting Mycobacterium tuberculosis in samples with different results by smear and culture in a coastal city with high incidence of tuberculosis.在结核病高发沿海城市中,Xpert MTB/RIF检测法对涂片和培养结果不同的样本中结核分枝杆菌的检测效能
BMC Infect Dis. 2025 Jan 11;25(1):55. doi: 10.1186/s12879-025-10446-z.
3

本文引用的文献

1
Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant Isolated From China.基因组分析鉴定出中国分离的耐多药菌株中与耐药性及北京基因型相关的突变。
Front Microbiol. 2020 Jul 15;11:1444. doi: 10.3389/fmicb.2020.01444. eCollection 2020.
2
Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species.结核分枝杆菌、ESKAPE 及其他细菌耐药相关基因突变的研究
Sci Rep. 2020 Jun 2;10(1):8957. doi: 10.1038/s41598-020-65766-8.
3
A Rapid and Accurate Detection Approach for Multidrug-Resistant Tuberculosis Based on PCR-ELISA Microplate Hybridization Assay.
Identification of Resistance to Common Antibiotics: An Overview of Current Methods and Techniques.
常见抗生素耐药性的鉴定:当前方法与技术概述
Infect Drug Resist. 2024 Apr 12;17:1491-1506. doi: 10.2147/IDR.S457308. eCollection 2024.
4
Advances in single-cell sequencing technology in microbiome research.微生物组研究中单细胞测序技术的进展。
Genes Dis. 2023 Sep 28;11(4):101129. doi: 10.1016/j.gendis.2023.101129. eCollection 2024 Jul.
5
Advances and Challenges in Cytomegalovirus Detection Methods for Liver Transplant Donors.肝移植供体巨细胞病毒检测方法的进展与挑战
Diagnostics (Basel). 2023 Oct 26;13(21):3310. doi: 10.3390/diagnostics13213310.
6
A color-based FHGC approach facilities DNA-based clinical molecular diagnostics.一种基于颜色的FHGC方法促进了基于DNA的临床分子诊断。
Genes Dis. 2022 Aug 5;10(4):1197-1199. doi: 10.1016/j.gendis.2022.07.007. eCollection 2023 Jul.
7
Advances in the application of molecular diagnostic techniques for the detection of infectious disease pathogens (Review).分子诊断技术在检测传染病病原体中的应用进展(综述)。
Mol Med Rep. 2023 May;27(5). doi: 10.3892/mmr.2023.12991. Epub 2023 Apr 7.
基于 PCR-ELISA 微孔板杂交分析的快速准确检测耐多药结核病方法。
Lab Med. 2020 Nov 2;51(6):606-613. doi: 10.1093/labmed/lmaa016.
4
Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.南非自由州省与耐多药结核病相关的异烟肼耐药突变体的流行情况。
S Afr Med J. 2019 Aug 28;109(9):659-664. doi: 10.7196/SAMJ.2019.v109i9.13730.
5
Recent updates on drug resistance in Mycobacterium tuberculosis.结核分枝杆菌耐药性的最新研究进展。
J Appl Microbiol. 2020 Jun;128(6):1547-1567. doi: 10.1111/jam.14478. Epub 2019 Oct 29.
6
Accuracy of molecular diagnostic tests for drug-resistant tuberculosis detection in China: a systematic review.中国耐药结核病分子诊断检测的准确性:系统评价。
Int J Tuberc Lung Dis. 2019 Aug 1;23(8):931-942. doi: 10.5588/ijtld.18.0550.
7
Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges.利用全基因组测序破译结核分枝杆菌的耐药性:进展、前景和挑战。
Genome Med. 2019 Jul 25;11(1):45. doi: 10.1186/s13073-019-0660-8.
8
Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.中国江西省耐多药结核分枝杆菌的流行状况和分子特征。
Sci Rep. 2019 May 13;9(1):7315. doi: 10.1038/s41598-019-43547-2.
9
Tuberculosis.肺结核。
Lancet. 2019 Apr 20;393(10181):1642-1656. doi: 10.1016/S0140-6736(19)30308-3. Epub 2019 Mar 20.
10
Advances in the molecular diagnosis of tuberculosis: From probes to genomes.结核病分子诊断的进展:从探针到基因组。
Infect Genet Evol. 2019 Aug;72:93-112. doi: 10.1016/j.meegid.2018.11.021. Epub 2018 Nov 30.